Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ezra pioneered fast, affordable full-body MRI scans enhanced by proprietary artificial intelligence. Its FDA-cleared platform can screen for potential cancers and over 500 other diseases in up to thirteen organs. The company's technology reduces scan time from one hour to as little as twenty-two minutes. Approximately six percent of scanned members have had potential cancers detected early. In February/March 2025, it received additional FDA clearance expanding its rapid scan capabilities across neuro, abdominal, and pelvic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ezra.